Cohort study: One in ten have long-term effects 8 months following mild COVID-19
One in ten have long-term effects 8 months following mild COVID-19 – Karolinska Institutet Original study: Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers – JAMA Commentary on Twitter #LongCovid in #Frontline: JAMA Worrisome! N=323 COVID+ #Healthcare Workers vs. N=1072 w no COVID. At 8 mos, up to 4x […]
The post Cohort study: One in ten have long-term effects 8 months following mild COVID-19 appeared first on Links Medicus.
Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records – The Lancet Psychiatry Commentaries: 1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds – STAT AND A longer look at COVID-19 and neuropsychiatric outcomes – The […]
The post Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions appeared first on Links Medicus.
Study finds low risk of venous thromboembolism in outpatients with Covid-19 – researchers advise against the use of anticoagulants outside clinical trials
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California – JAMA Internal Medicine Commentaries: VTE Related to SARS-CoV-2 Infection Less Of a Problem in Outpatients – TCTMD AND No Increase Seen in Outpatient VTE for SARS-CoV-2-Positive Patients – Physician’s Weekly Commentary on Twitter […]
The post Study finds low risk of venous thromboembolism in outpatients with Covid-19 – researchers advise against the use of anticoagulants outside clinical trials appeared first on Links Medicus.
Video: Coronavirus Variants and Vaccines
Coronavirus Variants and Vaccines – JAMA
The post Video: Coronavirus Variants and Vaccines appeared first on Links Medicus.
JCVI statement on use of the AstraZeneca COVID-19 vaccine: “JCVI currently advises that it is preferable for adults aged
JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021 – GOV.UK Commentaries: Covid: Under-30s offered alternative to Oxford-AstraZeneca jab – BBC AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare blood clots and low blood platelets – Science Media Centre
The post JCVI statement on use of the AstraZeneca COVID-19 vaccine: “JCVI currently advises that it is preferable for adults aged <30 years to be offered an alternative COVID-19 vaccine, if available.” appeared first on Links Medicus.
UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca
UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca – GOV.UK Original report: MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots – Medicines and Healthcare products Regulatory Agency Commentary: Expert reaction to statements from MHRA and EMA in relation […]
The post UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca appeared first on Links Medicus.
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. The benefits of the vaccine continue to outweigh the risks for people who receive it.
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets – European Medicines Agency Commentaries: In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say – STAT AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare […]
The post AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. The benefits of the vaccine continue to outweigh the risks for people who receive it. appeared first on Links Medicus.
Large study showed no association between blood group types and increased risk of Covid-19
Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population – JAMA Network Open Commentary on Twitter This case-control study found blood type A was not associated with higher nor type O with lower COVID-19 susceptibility or severity. Blood types were not prognostically useful. https://t.co/P8VpvQWuwE — JAMA Network […]
The post Large study showed no association between blood group types and increased risk of Covid-19 appeared first on Links Medicus.
What’s the new coronavirus variant in India and how should it change their COVID response?
What’s the new coronavirus variant in India and how should it change their COVID response? – The Conversation
The post What’s the new coronavirus variant in India and how should it change their COVID response? appeared first on Links Medicus.
Opinion | New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’
New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’ – The Conversation Commentary on Twitter ✨"COVID-19 variants of concern have changed the game. We need to recognise and act on this if we as a global society are to avoid future waves of infections, yet […]
The post Opinion | New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’ appeared first on Links Medicus.